Sleepy Hollow, NY
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP, founded in 2010, is a small nonprofit in the Medical Research sector that reported $378K in total revenue in fiscal year 2024. Revenue surged 130% from the prior year, signaling strong growth momentum. The organization ran a surplus of $148K, a strong 39% operating margin.
The mission of ITMIG is to promote the advancement of clinical and basic science pertaining to thymic and other mediastinal malignancies and related conditions ITMIG is a multidisciplinary group currently consisting of surgeons, pathologists, imaging specialists, oncologists, and neurologists, aiming for better management of patients with thymic tumors through an optimized interaction between the disciplines. The academic journal Mediastinum has become the official journal of the International Thymic Malignancy Interest Group! This represents a collaborative partnership between two institutions. The ITMIG database is a major resource for studying the characteristics, treatment strategies, and outcomes of patients with thymic malignancies, has reopened More than 2000 patients are enrolled. The Biology Working Group has been created, .
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2024 | 2023 | Change | |
|---|---|---|---|
| Revenue | $377,806 | $164,486 | +1.3% |
| Expenses | $229,580 | $138,896 | +0.7% |
| Net Income | $148,226 | $25,590 | +4.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| Pam Bruce | Director | 40.00 |
Key Emp
|
$0 | $0 | $0 |
| Dr Malgorzata Szolkowska | President | 25.00 |
Director
|
$0 | $0 | $0 |
| Dr Paolo Mendogni | Secretary | 25.00 |
Director
|
$0 | $0 | $0 |
| Dr Annemarie Fernandes Shepherd | Treasurer | 25.00 |
Director
|
$0 | $0 | $0 |
| Dr Dirk Van Raemdonck | Vjce President | 25.00 |
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | $377,806 | $229,580 | $316,149 | $148,226 |
| 2024 | $373,790 | $229,580 | $312,142 | $144,210 |
Compare INTERNATIONAL THYMIC MALIGNANCY INTEREST GROUP with other nonprofits in New York and across the country.